Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study-Reference-Cited by-同舟云学术

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study

Published:2023 Issue:16 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Oh Young Ju¹^ORCID,Kim Jongman²^ORCID,Kang Eun-Suk³^ORCID,Rhu Jinsoo²^ORCID,Choi Gyu-Seong²^ORCID,Joh Jae-Won²^ORCID

Affiliation:

1. Department of Surgery, Korea University Anam Hospital, Korea University School of Medicine, Seoul, Korea.

2. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e121

Reference10 articles.

1. Korea Centers for Disease Control and Prevention. Daily report of MERS. Updated 2016. Accessed October 1, 2022. http://www.mers.go.kr/mers/html/jsp/main.jsp

2. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

3. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

4. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

5. Ministry of Health and Welfare (KR). Coronavirus (COVID-19), Republic of Korea. Updated 2022. Accessed November 11, 2022. http://ncov.mohw.go.kr/en/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023;Journal of Korean Medical Science;2023

2. Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant;Journal of Korean Medical Science;2023